Rite Aid Corp (NYSE:RAD)

analysis

Short Sellers Go to War Against 8 Well-Known Stocks in May

Every two weeks brings new readings on the short interest on every Nasdaq and New York Stock Exchange listed stock. Some companies see short interest in their shares rise, and ...
Read Full Story »
Skunk in the Sun

Marijuana Weekly News Roundup

Walgreens Boots Alliance Inc. (NASDAQ: WBA) is the world's largest drug store chain and promises to grow even larger if its proposed merger with Rite Aid Inc. (NYSE: RAD) is ...
Read Full Story »
New York Stock Exchange

Top Analyst Upgrades and Downgrades: Apache, Baker Hughes, Intercept Pharmaceutical, Rite Aid, Synchrony Financial, US Steel and More

Well the volatility is back, at least for now, and Thursday's big loss is starting to remind investors how the first six weeks of the 2016 trading year went. The ...
Read Full Story »
Prescription drugs

Rite Aid Posts Solid Q4 Earnings

Rite Aid Corp. (NYSE: RAD) released its fiscal fourth-quarter earnings report before the markets opened on Thursday. The company said it had $0.07 in earnings per share (EPS) on $8.3 ...
Read Full Story »
Prescription drugs

What to Expect From Rite Aid Earnings

Rite Aid Corp. (NYSE: RAD) is scheduled to report its fiscal fourth-quarter financial results before the markets open on Thursday. The consensus estimates from Thomson Reuters call for $0.06 in ...
Read Full Story »
Profit or Loss

Top Earnings to Watch for the Week Ahead

24/7 Wall St. has put together a preview of some of the major companies reporting their quarterly results this week. We are just about to enter into an earnings season ...
Read Full Story »
Rite Aid

Credit Suisse Shows Why Rite Aid Might Be a Steal

Rite Aid Corp. (NYSE: RAD) remains caught in what many investors equate to a merger time warp. That often just might not mean that the low volatility in a post-merger ...
Read Full Story »
Shoppers

January Retail Sales Growth Estimate a Meager 0.2%

Same-store sales for the month of January were weak, but still a couple of ticks higher than January 2015. But fourth-quarter earnings look to be far worse — down 1.4%. ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Bluebird Bio, Check Point, Comcast, Eli Lilly, Hyatt, Lockheed Martin, Rite Aid and Many More

Stocks were pounded lower yet again on Wednesday, but this time on fears of a North Korean hydrogen bomb test. The stock market is off to a rocky start in ...
Read Full Story »
Rite Aid

Rite Aid Posts December and Year-to-Date Sales

Rite Aid Corp. (NYSE: RAD) is keeping its investors up to date with its most recent monthly sales report. The company reported its sales results for the month of December, ...
Read Full Story »
Rite Aid

Rite Aid Treading Water as Regulators Examine Acquisition

Rite Aid Corp. (NYSE: RAD) reported third-quarter fiscal 2016 results before markets opened Thursday. The drug store chain posted quarterly diluted earnings per share (EPS) of $0.06 on revenues of ...
Read Full Story »
coins

What to Expect From Rite Aid Earnings

Rite Aid Corp. (NYSE: RAD) is scheduled to report its fiscal third-quarter financial results before the markets open on Thursday. The consensus estimates from Thomson Reuters call for $0.06 in ...
Read Full Story »
Profit or Loss

Top 6 Earnings for the Week Ahead

24/7 Wall St. has put together a preview of some of the major companies reporting their quarterly results this week. We have included the consensus earnings estimates from Thomson Reuters ...
Read Full Story »
Prescription drugs

Rite Aid Announces November Sales

Rite Aid Corp. (NYSE: RAD) reported its sales results for its retail pharmacy segment for the month of November before the markets opened Thursday. For the five weeks that ended ...
Read Full Story »
buy sell

Top Analyst Upgrades and Downgrades: Anadarko, Buffalo Wild Wings, GoPro, LifeLock, Rite Aid, SunPower and More

Stocks were trading lower on Thursday, a day after the Federal Reserve sounded a touch less dovish (but still not hawkish) despite no rate hike. However, investors keep proving that ...
Read Full Story »